TNFSF10 and experimental autoimmune encephalomyelitis: It is noteworthy that TRAIL controls autoimmune inflammation, and Hilliard et al. (2001) demonstrated that TRAIL inhibits experimental autoimmune encephalomyelitis by preventing activation of autoimmune T cells (Hilliard et al., 2001).